Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Platelets in myeloproliferative neoplasms have a distinct transcript signature in the presence of marrow fibrosis.

Guo BB, Linden MD, Fuller KA, Phillips M, Mirzai B, Wilson L, Chuah H, Liang J, Howman R, Grove CS, Malherbe JA, Leahy MF, Allcock RJ, Erber WN.

Br J Haematol. 2020 Jan;188(2):272-282. doi: 10.1111/bjh.16152. Epub 2019 Aug 19.

PMID:
31426129
2.

"Immuno-flowFISH" for the Assessment of Cytogenetic Abnormalities in Chronic Lymphocytic Leukemia.

Hui HYL, Clarke KM, Fuller KA, Stanley J, Chuah HH, Ng TF, Cheah C, McQuillan A, Erber WN.

Cytometry A. 2019 May;95(5):521-533. doi: 10.1002/cyto.a.23769. Epub 2019 Apr 24.

PMID:
31016848
3.

Inherited missense variants that affect GFI1B function do not necessarily cause bleeding diatheses.

van Oorschot R, Marneth AE, Bergevoet SM, van Bergen MGJM, Peerlinck K, Lentaigne CE, Millar CM, Westbury SK, Favier R, Erber WN, Turro E, Jansen JH, Ouwehand WH, McKinney HL; NIHR BioResource Collaborative Group, Downes K, Freson K, van der Reijden BA.

Haematologica. 2019 Jun;104(6):e260-e264. doi: 10.3324/haematol.2018.207712. Epub 2018 Dec 20. No abstract available.

4.

Phenotype description and response to thrombopoietin receptor agonist in DIAPH1-related disorder.

Westbury SK, Downes K, Burney C, Lozano ML, Obaji SG, Toh CH, Sevivas T, Morgan NV, Erber WN, Kempster C, Moore SF, Thys C, Papadia S, Ouwehand WH; NIHR BioResource–Rare Diseases, Laffan MA, Gomez K, Freson K, Rivera J, Mumford AD.

Blood Adv. 2018 Sep 25;2(18):2341-2346. doi: 10.1182/bloodadvances.2018020370. No abstract available.

5.

Automated enumeration of lymphoid and plasma cells in bone marrow to establish normal reference ranges.

Liang J, Malherbe JAJ, Fuller KA, Mirzai B, George C, Carter TL, Cole CH, Guo BB, Meehan K, Erber WN.

J Clin Pathol. 2018 Oct;71(10):916-925. doi: 10.1136/jclinpath-2018-205168. Epub 2018 Jun 1.

PMID:
29858232
6.

Imaging flow cytometry to assess chromosomal abnormalities in chronic lymphocytic leukaemia.

Hui H, Fuller KA, Chuah H, Liang J, Sidiqi H, Radeski D, Erber WN.

Methods. 2018 Feb 1;134-135:32-40. doi: 10.1016/j.ymeth.2017.11.003. Epub 2017 Nov 15.

PMID:
29155042
7.

A mutation in PTPN11 may drive leukemic transformation in a case of essential thrombocythemia.

Guo BB, Liang J, Allcock RJN, Mirzai B, Augustson B, Howman R, Fuller KA, Erber WN.

Leuk Lymphoma. 2018 Jan;59(1):245-248. doi: 10.1080/10428194.2017.1324162. Epub 2017 Jun 7. No abstract available.

PMID:
28587547
8.

Megakaryocytes in Myeloproliferative Neoplasms Have Unique Somatic Mutations.

Guo BB, Allcock RJ, Mirzai B, Malherbe JA, Choudry FA, Frontini M, Chuah H, Liang J, Kavanagh SE, Howman R, Ouwehand WH, Fuller KA, Erber WN.

Am J Pathol. 2017 Jul;187(7):1512-1522. doi: 10.1016/j.ajpath.2017.03.009. Epub 2017 May 11.

9.

HER2 mRNA transcript quantitation in breast cancer.

Meehan K, Clynick B, Mirzai B, Maslen P, Harvey JM, Erber WN.

Clin Transl Oncol. 2017 May;19(5):606-615. doi: 10.1007/s12094-016-1573-2. Epub 2016 Nov 11.

PMID:
27837339
10.

Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial : A randomized trial of IV iron in critical illness.

IRONMAN Investigators, Litton E, Baker S, Erber WN, Farmer S, Ferrier J, French C, Gummer J, Hawkins D, Higgins A, Hofmann A, De Keulenaer B, McMorrow J, Olynyk JK, Richards T, Towler S, Trengove R, Webb S; Australian and New Zealand Intensive Care Society Clinical Trials Group.

Intensive Care Med. 2016 Nov;42(11):1715-1722. Epub 2016 Sep 30.

PMID:
27686346
11.

Imaging flow cytometry in the assessment of leukocyte-platelet aggregates.

Hui H, Fuller KA, Erber WN, Linden MD.

Methods. 2017 Jan 1;112:46-54. doi: 10.1016/j.ymeth.2016.10.002. Epub 2016 Oct 5.

PMID:
27720831
12.

Applications of imaging flow cytometry in the diagnostic assessment of acute leukaemia.

Grimwade LF, Fuller KA, Erber WN.

Methods. 2017 Jan 1;112:39-45. doi: 10.1016/j.ymeth.2016.06.023. Epub 2016 Jul 6. Review.

PMID:
27394668
13.

Development of a robust immuno-S-FISH protocol using imaging flow cytometry.

Fuller KA, Bennett S, Hui H, Chakera A, Erber WN.

Cytometry A. 2016 Aug;89(8):720-30. doi: 10.1002/cyto.a.22852. Epub 2016 May 3.

14.

An active, collaborative approach to learning skills in flow cytometry.

Fuller K, Linden MD, Lee-Pullen T, Fragall C, Erber WN, Röhrig KJ.

Adv Physiol Educ. 2016 Jun;40(2):176-85. doi: 10.1152/advan.00002.2015.

15.

Dysregulation of the intrinsic apoptotic pathway mediates megakaryocytic hyperplasia in myeloproliferative neoplasms.

Malherbe JA, Fuller KA, Mirzai B, Kavanagh S, So CC, Ip HW, Guo BB, Forsyth C, Howman R, Erber WN.

J Clin Pathol. 2016 Apr 8. pii: jclinpath-2016-203625. doi: 10.1136/jclinpath-2016-203625. [Epub ahead of print]

16.

TGFα expression in myeloid malignancies.

Kavanagh S, Mirzai B, Fuller K, Erber WN.

J Clin Pathol. 2016 Jun;69(6):543-6. doi: 10.1136/jclinpath-2015-203526. Epub 2016 Mar 16.

17.

A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies.

Turro E, Greene D, Wijgaerts A, Thys C, Lentaigne C, Bariana TK, Westbury SK, Kelly AM, Selleslag D, Stephens JC, Papadia S, Simeoni I, Penkett CJ, Ashford S, Attwood A, Austin S, Bakchoul T, Collins P, Deevi SV, Favier R, Kostadima M, Lambert MP, Mathias M, Millar CM, Peerlinck K, Perry DJ, Schulman S, Whitehorn D, Wittevrongel C; BRIDGE-BPD Consortium, De Maeyer M, Rendon A, Gomez K, Erber WN, Mumford AD, Nurden P, Stirrups K, Bradley JR, Raymond FL, Laffan MA, Van Geet C, Richardson S, Freson K, Ouwehand WH.

Sci Transl Med. 2016 Mar 2;8(328):328ra30. doi: 10.1126/scitranslmed.aad7666. Epub 2016 Mar 2.

18.

A gain-of-function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss.

Stritt S, Nurden P, Turro E, Greene D, Jansen SB, Westbury SK, Petersen R, Astle WJ, Marlin S, Bariana TK, Kostadima M, Lentaigne C, Maiwald S, Papadia S, Kelly AM, Stephens JC, Penkett CJ, Ashford S, Tuna S, Austin S, Bakchoul T, Collins P, Favier R, Lambert MP, Mathias M, Millar CM, Mapeta R, Perry DJ, Schulman S, Simeoni I, Thys C; BRIDGE-BPD Consortium, Gomez K, Erber WN, Stirrups K, Rendon A, Bradley JR, van Geet C, Raymond FL, Laffan MA, Nurden AT, Nieswandt B, Richardson S, Freson K, Ouwehand WH, Mumford AD.

Blood. 2016 Jun 9;127(23):2903-14. doi: 10.1182/blood-2015-10-675629. Epub 2016 Feb 24.

19.

TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy.

Nievergall E, Reynolds J, Kok CH, Watkins DB, Biondo M, Busfield SJ, Vairo G, Fuller K, Erber WN, Sadras T, Grose R, Yeung DT, Lopez AF, Hiwase DK, Hughes TP, White DL.

Leukemia. 2016 Jun;30(6):1263-72. doi: 10.1038/leu.2016.34. Epub 2016 Feb 22.

PMID:
26898188
20.

Megakaryocytic hyperplasia in myeloproliferative neoplasms is driven by disordered proliferative, apoptotic and epigenetic mechanisms.

Malherbe JA, Fuller KA, Arshad A, Nangalia J, Romeo G, Hall SL, Meehan KS, Guo B, Howman R, Erber WN.

J Clin Pathol. 2016 Feb;69(2):155-63. doi: 10.1136/jclinpath-2015-203177. Epub 2015 Aug 19.

21.

Somatic mutations in glioblastoma are associated with methylguanine-DNA methyltransferase methylation.

McDonald KL, Tabone T, Nowak AK, Erber WN.

Oncol Lett. 2015 May;9(5):2063-2067. Epub 2015 Feb 20.

22.

Human phenotype ontology annotation and cluster analysis to unravel genetic defects in 707 cases with unexplained bleeding and platelet disorders.

Westbury SK, Turro E, Greene D, Lentaigne C, Kelly AM, Bariana TK, Simeoni I, Pillois X, Attwood A, Austin S, Jansen SB, Bakchoul T, Crisp-Hihn A, Erber WN, Favier R, Foad N, Gattens M, Jolley JD, Liesner R, Meacham S, Millar CM, Nurden AT, Peerlinck K, Perry DJ, Poudel P, Schulman S, Schulze H, Stephens JC, Furie B, Robinson PN, van Geet C, Rendon A, Gomez K, Laffan MA, Lambert MP, Nurden P, Ouwehand WH, Richardson S, Mumford AD, Freson K; BRIDGE-BPD Consortium.

Genome Med. 2015 Apr 9;7(1):36. doi: 10.1186/s13073-015-0151-5. eCollection 2015.

23.

BRAF mutation detection in hairy cell leukaemia from archival haematolymphoid specimens.

Thomas C, Amanuel B, Finlayson J, Grieu-Iacopetta F, Spagnolo DV, Erber WN.

Pathology. 2015 Jun;47(4):349-54. doi: 10.1097/PAT.0000000000000245.

PMID:
25938346
24.

Measurement of monocyte-platelet aggregates by imaging flow cytometry.

Hui H, Fuller K, Erber WN, Linden MD.

Cytometry A. 2015 Mar;87(3):273-8. doi: 10.1002/cyto.a.22587. Epub 2014 Dec 16.

25.

Disruption of IKAROS activity in primitive chronic-phase CML cells mimics myeloid disease progression.

Beer PA, Knapp DJ, Miller PH, Kannan N, Sloma I, Heel K, Babovic S, Bulaeva E, Rabu G, Terry J, Druker BJ, Loriaux MM, Loeb KR, Radich JP, Erber WN, Eaves CJ.

Blood. 2015 Jan 15;125(3):504-15. doi: 10.1182/blood-2014-06-581173. Epub 2014 Nov 4.

26.

Gray platelet syndrome: proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice.

Guerrero JA, Bennett C, van der Weyden L, McKinney H, Chin M, Nurden P, McIntyre Z, Cambridge EL, Estabel J, Wardle-Jones H, Speak AO, Erber WN, Rendon A, Ouwehand WH, Ghevaert C.

Blood. 2014 Dec 4;124(24):3624-35. doi: 10.1182/blood-2014-04-566760. Epub 2014 Sep 25.

PMID:
25258341
27.

Transcriptional diversity during lineage commitment of human blood progenitors.

Chen L, Kostadima M, Martens JHA, Canu G, Garcia SP, Turro E, Downes K, Macaulay IC, Bielczyk-Maczynska E, Coe S, Farrow S, Poudel P, Burden F, Jansen SBG, Astle WJ, Attwood A, Bariana T, de Bono B, Breschi A, Chambers JC, Consortium B, Choudry FA, Clarke L, Coupland P, van der Ent M, Erber WN, Jansen JH, Favier R, Fenech ME, Foad N, Freson K, van Geet C, Gomez K, Guigo R, Hampshire D, Kelly AM, Kerstens HHD, Kooner JS, Laffan M, Lentaigne C, Labalette C, Martin T, Meacham S, Mumford A, Nürnberg S, Palumbo E, van der Reijden BA, Richardson D, Sammut SJ, Slodkowicz G, Tamuri AU, Vasquez L, Voss K, Watt S, Westbury S, Flicek P, Loos R, Goldman N, Bertone P, Read RJ, Richardson S, Cvejic A, Soranzo N, Ouwehand WH, Stunnenberg HG, Frontini M, Rendon A.

Science. 2014 Sep 26;345(6204):1251033. doi: 10.1126/science.1251033.

28.

Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.

Tabone T, Abuhusain HJ, Nowak AK; Australian Genomics and Clinical Outcome of Glioma (AGOG) Network, Erber WN, McDonald KL.

J Clin Pathol. 2014 Jul;67(7):550-5. doi: 10.1136/jclinpath-2014-202173. Epub 2014 Apr 2.

PMID:
24695838
29.

Developments in the immunophenotypic analysis of haematological malignancies.

Heel K, Tabone T, Röhrig KJ, Maslen PG, Meehan K, Grimwade LF, Erber WN.

Blood Rev. 2013 Jul;27(4):193-207. doi: 10.1016/j.blre.2013.06.005. Epub 2013 Jul 8. Review.

PMID:
23845589
30.

Chronic neutrophilic leukemia with plasma cell dyscrasia: friends or relatives?

Erber WN, Reilly JT.

Leuk Lymphoma. 2014 Feb;55(2):240-2. doi: 10.3109/10428194.2013.803549. Epub 2013 Jun 12. No abstract available.

PMID:
23656197
31.

Detection of cytoplasmic nucleophosmin expression by imaging flow cytometry.

Grimwade L, Gudgin E, Bloxham D, Bottley G, Vassiliou G, Huntly B, Scott MA, Erber WN.

Cytometry A. 2012 Oct;81(10):896-900. doi: 10.1002/cyto.a.22116. Epub 2012 Sep 11.

32.

Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease.

Royo C, Navarro A, Clot G, Salaverria I, Giné E, Jares P, Colomer D, Wiestner A, Wilson WH, Vegliante MC, Fernandez V, Hartmann EM, Trim N, Erber WN, Swerdlow SH, Klapper W, Dyer MJ, Vargas-Pabón M, Ott G, Rosenwald A, Siebert R, López-Guillermo A, Campo E, Beà S.

Leukemia. 2012 Aug;26(8):1895-8. doi: 10.1038/leu.2012.72. Epub 2012 Mar 19. No abstract available.

33.

Hematologic features of hepatosplenic T-cell lymphoma.

Erber WN, Finlayson J.

Am J Clin Pathol. 2012 Feb;137(2):334-5. doi: 10.1309/AJCPVBI47QPVTJOW. No abstract available.

34.

[Diagnosis in incidental eosinophilia findings].

Sims H, Erber WN.

Praxis (Bern 1994). 2012 Jan 18;101(2):123-5. doi: 10.1024/1661-8157/a000844. German. No abstract available.

PMID:
22252594
35.

Investigation of an incidental finding of eosinophilia.

Sims H, Erber WN.

BMJ. 2011 May 18;342:d2670. doi: 10.1136/bmj.d2670. No abstract available.

PMID:
21593088
36.

PML protein analysis using imaging flow cytometry.

Grimwade L, Gudgin E, Bloxham D, Scott MA, Erber WN.

J Clin Pathol. 2011 May;64(5):447-50. doi: 10.1136/jcp.2010.085662. Epub 2010 Dec 22.

PMID:
21177751
37.

How I treat essential thrombocythemia.

Beer PA, Erber WN, Campbell PJ, Green AR.

Blood. 2011 Feb 3;117(5):1472-82. doi: 10.1182/blood-2010-08-270033. Epub 2010 Nov 24.

38.

New insights into 5q- syndrome as a ribosomopathy.

Barlow JL, Drynan LF, Trim NL, Erber WN, Warren AJ, McKenzie AN.

Cell Cycle. 2010 Nov 1;9(21):4286-93. Epub 2010 Nov 22. Review.

PMID:
20980806
39.

JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia.

Li J, Spensberger D, Ahn JS, Anand S, Beer PA, Ghevaert C, Chen E, Forrai A, Scott LM, Ferreira R, Campbell PJ, Watson SP, Liu P, Erber WN, Huntly BJ, Ottersbach K, Green AR.

Blood. 2010 Sep 2;116(9):1528-38. doi: 10.1182/blood-2009-12-259747. Epub 2010 May 20.

40.

Clinical utility of routine MPL exon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis.

Boyd EM, Bench AJ, Goday-Fernández A, Anand S, Vaghela KJ, Beer P, Scott MA, Bareford D, Green AR, Huntly B, Erber WN.

Br J Haematol. 2010 Apr;149(2):250-7. doi: 10.1111/j.1365-2141.2010.08083.x. Epub 2010 Feb 11.

PMID:
20151976
41.

Can cytoplasmic nucleophosmin be detected by immunocytochemical staining of cell smears in acute myeloid leukemia?

Mattsson G, Turner SH, Cordell J, Ferguson DJ, Schuh A, Grimwade LF, Bench AJ, Weinberg OK, Marafioti T, George TI, Arber DA, Erber WN, Mason DY.

Haematologica. 2010 Apr;95(4):670-3. doi: 10.3324/haematol.2009.011817. Epub 2009 Dec 16.

42.

Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms.

Grimwade LF, Happerfield L, Tristram C, McIntosh G, Rees M, Bench AJ, Boyd EM, Hall M, Quinn A, Piggott N, Scorer P, Scott MA, Erber WN.

Br J Haematol. 2009 Nov;147(4):495-506. doi: 10.1111/j.1365-2141.2009.07870.x. Epub 2009 Aug 31.

PMID:
19747364
43.

Incidental finding of lymphocytosis in an asymptomatic patient.

Grove CS, Follows GA, Erber WN.

BMJ. 2009 Jun 10;338:b2119. doi: 10.1136/bmj.b2119. No abstract available.

PMID:
19515711
44.

Reticulin accumulation in essential thrombocythemia: prognostic significance and relationship to therapy.

Campbell PJ, Bareford D, Erber WN, Wilkins BS, Wright P, Buck G, Wheatley K, Harrison CN, Green AR.

J Clin Oncol. 2009 Jun 20;27(18):2991-9. doi: 10.1200/JCO.2008.20.3174. Epub 2009 Apr 13.

45.

Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. Clinical article.

Tseng MY, Hutchinson PJ, Richards HK, Czosnyka M, Pickard JD, Erber WN, Brown S, Kirkpatrick PJ.

J Neurosurg. 2009 Jul;111(1):171-80. doi: 10.3171/2009.3.JNS081332.

PMID:
19344224
46.

Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clones.

Beer PA, Jones AV, Bench AJ, Goday-Fernandez A, Boyd EM, Vaghela KJ, Erber WN, Odeh B, Wright C, McMullin MF, Cullis J, Huntly BJ, Harrison CN, Cross NC, Green AR.

Br J Haematol. 2009 Mar;144(6):904-8. doi: 10.1111/j.1365-2141.2008.07560.x. Epub 2009 Jan 16.

PMID:
19170680
47.

Therapy-related acute myeloid leukaemia with t(8;16)(p11;p13);MOZ-CBP and polymorphisms in detoxifying and DNA repair genes.

Boyd EM, Bench AJ, Vaghela KJ, Campbell GN, Chowdhury FB, Gudgin EJ, Scott MA, Erber WN.

Leukemia. 2009 Jun;23(6):1164-7. doi: 10.1038/leu.2008.383. Epub 2009 Jan 22. No abstract available.

PMID:
19158836
48.

ICSH guidelines for the standardization of bone marrow specimens and reports.

Lee SH, Erber WN, Porwit A, Tomonaga M, Peterson LC; International Council for Standardization In Hematology.

Int J Lab Hematol. 2008 Oct;30(5):349-64. doi: 10.1111/j.1751-553X.2008.01100.x.

PMID:
18822060
49.

A novel CD11c monoclonal antibody effective in formalin-fixed tissue for the diagnosis of hairy cell leukemia.

Johrens K, Happerfield LC, Brown JP, Erber WN, Stein H, Anagnostopoulos I.

Pathobiology. 2008;75(4):252-6. doi: 10.1159/000132386. Epub 2008 Jun 26.

50.

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort.

Beer PA, Campbell PJ, Scott LM, Bench AJ, Erber WN, Bareford D, Wilkins BS, Reilly JT, Hasselbalch HC, Bowman R, Wheatley K, Buck G, Harrison CN, Green AR.

Blood. 2008 Jul 1;112(1):141-9. doi: 10.1182/blood-2008-01-131664. Epub 2008 May 1.

PMID:
18451306

Supplemental Content

Loading ...
Support Center